Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets - License Agreements (Details)

v3.20.1
Intangible Assets - License Agreements (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Sales and Marketing Expense    
Intangible assets    
Royalty fees included in sales and marketing expense $ 492,000 $ 449,000
License Agreements    
Intangible assets    
Notice period for termination of license agreements 60 days  
Minimum royalty of agreements $ 12,500  
Milestone fee upon receiving a Phase II Small Business Innovation Research 15,000  
Milestone fee upon FDA approval 125,000  
Milestone fee upon first commercial use of certain licensed technology 25,000  
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products $ 10,000  
License Agreements | Minimum    
Intangible assets    
Royalty fees range under the license agreements 1.00%  
License Agreements | Maximum    
Intangible assets    
Royalty fees range under the license agreements 3.00%  
Royalty stack cap for royalties paid to more than one licensor for sales of the same product 3.75%